General Information of Drug Off-Target (DOT) (ID: OTAZ9QDX)

DOT Name T-box transcription factor TBX15 (TBX15)
Synonyms T-box protein 15; T-box transcription factor TBX14; T-box protein 14
Gene Name TBX15
Related Disease
Pelviscapular dysplasia ( )
Epithelial ovarian cancer ( )
Neoplasm ( )
Obesity ( )
Ovarian cancer ( )
Ovarian neoplasm ( )
Prostate cancer ( )
Prostate carcinoma ( )
Thyroid cancer ( )
Thyroid gland carcinoma ( )
Thyroid tumor ( )
Advanced cancer ( )
Alopecia ( )
Androgenetic alopecia ( )
Baldness, male pattern ( )
UniProt ID
TBX15_HUMAN
3D Structure
Download
2D Sequence (FASTA)
Download
3D Structure (PDB)
Download
Pfam ID
PF00907
Sequence
MSERRRSAVALSSRAHAFSVEALIGSNKKRKLRDWEEKGLDLSMEALSPAGPLGDTEDAA
AHGLEPHPDSEQSTGSDSEVLTERTSCSFSTHTDLASGAAGPVPAAMSSMEEIQVELQCA
DLWKRFHDIGTEMIITKAGRRMFPAMRVKITGLDPHQQYYIAMDIVPVDNKRYRYVYHSS
KWMVAGNADSPVPPRVYIHPDSLASGDTWMRQVVSFDKLKLTNNELDDQGHIILHSMHKY
QPRVHVIRKDFSSDLSPTKPVPVGDGVKTFNFPETVFTTVTAYQNQQITRLKIDRNPFAK
GFRDSGRNRTGLEAIMETYAFWRPPVRTLTFEDFTTMQKQQGGSTGTSPTTSSTGTPSPS
ASSHLLSPSCSPPTFHLAPNTFNVGCRESQLCNLNLSDYPPCARSNMAALQSYPGLSDSG
YNRLQSGTTSATQPSETFMPQRTPSLISGIPTPPSLPGNSKMEAYGGQLGSFPTSQFQYV
MQAGNAASSSSSPHMFGGSHMQQSSYNAFSLHNPYNLYGYNFPTSPRLAASPEKLSASQS
TLLCSSPSNGAFGERQYLPSGMEHSMHMISPSPNNQQATNTCDGRQYGAVPGSSSQMSVH
MV
Function Probable transcriptional regulator involved in the development of the skeleton of the limb, vertebral column and head. Acts by controlling the number of mesenchymal precursor cells and chondrocytes.

Molecular Interaction Atlas (MIA) of This DOT

15 Disease(s) Related to This DOT
Disease Name Disease ID Evidence Level Mode of Inheritance REF
Pelviscapular dysplasia DISPNJ3R Definitive Autosomal recessive [1]
Epithelial ovarian cancer DIS56MH2 Strong Biomarker [2]
Neoplasm DISZKGEW Strong Biomarker [3]
Obesity DIS47Y1K Strong Biomarker [4]
Ovarian cancer DISZJHAP Strong Biomarker [2]
Ovarian neoplasm DISEAFTY Strong Biomarker [2]
Prostate cancer DISF190Y Strong Altered Expression [5]
Prostate carcinoma DISMJPLE Strong Altered Expression [5]
Thyroid cancer DIS3VLDH moderate Biomarker [6]
Thyroid gland carcinoma DISMNGZ0 moderate Biomarker [6]
Thyroid tumor DISLVKMD moderate Biomarker [6]
Advanced cancer DISAT1Z9 Limited Genetic Variation [5]
Alopecia DIS37HU4 Limited Genetic Variation [7]
Androgenetic alopecia DISSJR1P Limited Genetic Variation [8]
Baldness, male pattern DIS9C9RO Limited Genetic Variation [8]
------------------------------------------------------------------------------------
⏷ Show the Full List of 15 Disease(s)
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This DOT
10 Drug(s) Affected the Gene/Protein Processing of This DOT
Drug Name Drug ID Highest Status Interaction REF
Valproate DMCFE9I Approved Valproate increases the expression of T-box transcription factor TBX15 (TBX15). [9]
Ciclosporin DMAZJFX Approved Ciclosporin decreases the expression of T-box transcription factor TBX15 (TBX15). [10]
Cisplatin DMRHGI9 Approved Cisplatin increases the expression of T-box transcription factor TBX15 (TBX15). [11]
Temozolomide DMKECZD Approved Temozolomide decreases the expression of T-box transcription factor TBX15 (TBX15). [12]
Calcitriol DM8ZVJ7 Approved Calcitriol increases the expression of T-box transcription factor TBX15 (TBX15). [13]
Testosterone DM7HUNW Approved Testosterone decreases the expression of T-box transcription factor TBX15 (TBX15). [13]
Permethrin DMZ0Q1G Approved Permethrin decreases the expression of T-box transcription factor TBX15 (TBX15). [14]
Urethane DM7NSI0 Phase 4 Urethane decreases the expression of T-box transcription factor TBX15 (TBX15). [15]
Dihydrotestosterone DM3S8XC Phase 4 Dihydrotestosterone increases the expression of T-box transcription factor TBX15 (TBX15). [16]
GALLICACID DM6Y3A0 Investigative GALLICACID decreases the expression of T-box transcription factor TBX15 (TBX15). [19]
------------------------------------------------------------------------------------
⏷ Show the Full List of 10 Drug(s)
2 Drug(s) Affected the Post-Translational Modifications of This DOT
Drug Name Drug ID Highest Status Interaction REF
Benzo(a)pyrene DMN7J43 Phase 1 Benzo(a)pyrene increases the methylation of T-box transcription factor TBX15 (TBX15). [17]
Sulforaphane DMQY3L0 Investigative Sulforaphane decreases the methylation of T-box transcription factor TBX15 (TBX15). [18]
------------------------------------------------------------------------------------

References

1 TBX15 mutations cause craniofacial dysmorphism, hypoplasia of scapula and pelvis, and short stature in Cousin syndrome. Am J Hum Genet. 2008 Nov;83(5):649-55. doi: 10.1016/j.ajhg.2008.10.011.
2 Ovarian cancer detection by DNA methylation in cervical scrapings.Clin Epigenetics. 2019 Nov 27;11(1):166. doi: 10.1186/s13148-019-0773-3.
3 Distinct DNA methylation alterations are associated with cribriform architecture and intraductal carcinoma in Gleason pattern 4 prostate tumors.Oncol Lett. 2017 Jul;14(1):390-396. doi: 10.3892/ol.2017.6140. Epub 2017 May 9.
4 Tbx15 is required for adipocyte browning induced by adrenergic signaling pathway.Mol Metab. 2019 Oct;28:48-57. doi: 10.1016/j.molmet.2019.07.004. Epub 2019 Jul 5.
5 NF-B Mediates the Expression of TBX15 in Cancer Cells.PLoS One. 2016 Jun 21;11(6):e0157761. doi: 10.1371/journal.pone.0157761. eCollection 2016.
6 Novel antiapoptotic effect of TBX15: overexpression of TBX15 reduces apoptosis in cancer cells.Apoptosis. 2015 Oct;20(10):1338-46. doi: 10.1007/s10495-015-1155-8.
7 Genetic prediction of male pattern baldness.PLoS Genet. 2017 Feb 14;13(2):e1006594. doi: 10.1371/journal.pgen.1006594. eCollection 2017 Feb.
8 GWAS for male-pattern baldness identifies 71 susceptibility loci explaining 38% of the risk.Nat Commun. 2017 Nov 17;8(1):1584. doi: 10.1038/s41467-017-01490-8.
9 A transcriptome-based classifier to identify developmental toxicants by stem cell testing: design, validation and optimization for histone deacetylase inhibitors. Arch Toxicol. 2015 Sep;89(9):1599-618.
10 Integrative "-Omics" analysis in primary human hepatocytes unravels persistent mechanisms of cyclosporine A-induced cholestasis. Chem Res Toxicol. 2016 Dec 19;29(12):2164-2174.
11 Activation of AIFM2 enhances apoptosis of human lung cancer cells undergoing toxicological stress. Toxicol Lett. 2016 Sep 6;258:227-236.
12 Temozolomide induces activation of Wnt/-catenin signaling in glioma cells via PI3K/Akt pathway: implications in glioma therapy. Cell Biol Toxicol. 2020 Jun;36(3):273-278. doi: 10.1007/s10565-019-09502-7. Epub 2019 Nov 22.
13 Effects of 1alpha,25 dihydroxyvitamin D3 and testosterone on miRNA and mRNA expression in LNCaP cells. Mol Cancer. 2011 May 18;10:58.
14 Exposure to Insecticides Modifies Gene Expression and DNA Methylation in Hematopoietic Tissues In Vitro. Int J Mol Sci. 2023 Mar 26;24(7):6259. doi: 10.3390/ijms24076259.
15 Ethyl carbamate induces cell death through its effects on multiple metabolic pathways. Chem Biol Interact. 2017 Nov 1;277:21-32.
16 LSD1 activates a lethal prostate cancer gene network independently of its demethylase function. Proc Natl Acad Sci U S A. 2018 May 1;115(18):E4179-E4188.
17 Air pollution and DNA methylation alterations in lung cancer: A systematic and comparative study. Oncotarget. 2017 Jan 3;8(1):1369-1391. doi: 10.18632/oncotarget.13622.
18 Transcriptome and DNA methylation changes modulated by sulforaphane induce cell cycle arrest, apoptosis, DNA damage, and suppression of proliferation in human liver cancer cells. Food Chem Toxicol. 2020 Feb;136:111047. doi: 10.1016/j.fct.2019.111047. Epub 2019 Dec 12.
19 Gene expression profile analysis of gallic acid-induced cell death process. Sci Rep. 2021 Aug 18;11(1):16743. doi: 10.1038/s41598-021-96174-1.